Sarcoma histiocítico em cães

Detalhes bibliográficos
Ano de defesa: 2022
Autor(a) principal: Luz, Flávia Serena da
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Brasil
Medicina Veterinária
UFSM
Programa de Pós-Graduação em Medicina Veterinária
Centro de Ciências Rurais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://repositorio.ufsm.br/handle/1/30087
Resumo: Histiocytic sarcoma is a malignant, progressive, and uncommon neoplasm that is part of a group of proliferative histiocytic diseases. This form of cancer originates from histiocytic cells, such as antigen-presenting cells, including Langerhans cells, and macrophages. The tumor can affect different species, but it is most commonly diagnosed in dogs. Epidemiologically, it is known that there is a predilection for large dogs and for some specific breeds, such as the Bernese Mountain dog. Article 1 of this thesis presents the results of a retrospective study aimed at definitively diagnosing and characterizing the epidemiology, anatomopathology and immunophenotypic behavior of histiocytic sarcoma. Histopathology results were obtained that reinforce some classic concepts, such as the importance in the presence of mono, bi and multinucleated giant cells for a strong diagnostic suspicion, as well as others that expand the knowledge about this form of cancer, such as the predisposition in Rottweiler dogs. Article 2 of this thesis presents the description of three cases of hemophagocytic histiocytic sarcoma, a rare variant that leads to hemolytic crisis and its consequences. The diagnosis was made by the association of clinical, laboratory, anatomopathological, and immunohistochemistry. In both articles it was possible to describe the immunophenotypic behavior of neoplastic cells against markers CD204, MHC-II and CD11d. Histiocytic sarcoma has become an increasingly frequent diagnosis in dogs in the routine of the laboratory of veterinary pathology, presenting itself as an interesting form of cancer to be studied, for a better understanding of its pathogenic mechanisms and variations regarding to immunophenotyping.